Michigan Senate Bill SB0621

Michigan 2023-2024 Regular Session

• Introduced: 10/26/23
• Refer: 10/26/23

Caption

Criminal procedure: sentencing guidelines; sentencing guidelines for conducting pathogen enhancement engineering or research; provide for. Amends sec. 13k of 1927 PA 175 (MCL 777.13k). TIE BAR WITH: SB 0620'23

Summary

Senate Bill No. 621 proposes significant amendments to the Michigan code of criminal procedure, specifically altering sentencing guidelines associated with felonies outlined in Chapter 333 of the Michigan Compiled Laws. The bill aims to address serious crimes related to pathogen enhancement engineering or research, encompassing actions involving human embryos, fetuses, and neonates. By explicitly defining these actions within the legislative framework, the bill seeks to create a more structured penal response to violations of these sensitive biomedical practices. Notably, the legislation introduces a tiered classification system for offenses related to conducting pathogen enhancement research, utilizing live human embryos for nontherapeutic purposes, and improper handling of fetal or embryonic material. Offenses get categorized to enhance clarity in punishment, ensuring that penalties are commensurate with the severity of the crime. This move reflects an increased emphasis on public safety and ethical standards in medical and scientific research fields. The bill is not without its points of contention. Critics argue that the language and scope of the bill could lead to unintended consequences, particularly regarding ethical research practices and personal freedoms tied to reproductive rights. Some stakeholders express concern that overly stringent regulations may stifle necessary medical research or dissuade innovation in pathogen research—an area that is essential in combating infectious diseases. Additionally, Senate Bill 621 is tied to Senate Bill 620, indicating a coordinated legislative effort to address these issues comprehensively. The relationship between the two bills suggests a broader legislative agenda focused on regulating complex and ethically sensitive areas of science and health, particularly as they pertain to the use of human biological materials.